PROB Stock Overview
Researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for PROB from our risk checks.
Probi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 258.00 |
| 52 Week High | SEK 319.00 |
| 52 Week Low | SEK 181.00 |
| Beta | 0.46 |
| 11 Month Change | -4.09% |
| 3 Month Change | -3.37% |
| 1 Year Change | 28.36% |
| 33 Year Change | -37.98% |
| 5 Year Change | -6.69% |
| Change since IPO | 621.68% |
Recent News & Updates
Recent updates
Probi's (STO:PROB) Anemic Earnings Might Be Worse Than You Think
Jul 24
There's No Escaping Probi AB (publ)'s (STO:PROB) Muted Revenues Despite A 43% Share Price Rise
Jun 26Should You Be Adding Probi (STO:PROB) To Your Watchlist Today?
Sep 08Estimating The Intrinsic Value Of Probi AB (publ) (STO:PROB)
Aug 12Is Now The Time To Put Probi (STO:PROB) On Your Watchlist?
May 26Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 19% Below Its Share Price
May 05Is Probi AB (publ)'s (STO:PROB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Mar 05Here's Why I Think Probi (STO:PROB) Might Deserve Your Attention Today
Feb 15Here's What Probi AB (publ)'s (STO:PROB) Shareholder Ownership Structure Looks Like
Jan 29
Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 20% Below Its Share Price
Jan 11Have Insiders Been Buying Probi AB (publ) (STO:PROB) Shares?
Dec 22Has Probi AB (publ)'s (STO:PROB) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 03Shareholder Returns
| PROB | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -3.7% | -5.6% | -3.6% |
| 1Y | 28.4% | 17.3% | 12.3% |
Return vs Industry: PROB exceeded the Swedish Biotechs industry which returned 19.4% over the past year.
Return vs Market: PROB exceeded the Swedish Market which returned 13.4% over the past year.
Price Volatility
| PROB volatility | |
|---|---|
| PROB Average Weekly Movement | 6.2% |
| Biotechs Industry Average Movement | 9.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: PROB has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: PROB's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 157 | Anita Johansen | www.probi.com |
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children’s, women’s, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, chilled diary and plant based products, frozen desserts and ice-cream, powder formulas, and recovery drinks.
Probi AB (publ) Fundamentals Summary
| PROB fundamental statistics | |
|---|---|
| Market cap | SEK 2.94b |
| Earnings (TTM) | SEK 10.88m |
| Revenue (TTM) | SEK 630.39m |
270.1x
P/E Ratio4.7x
P/S RatioIs PROB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PROB income statement (TTM) | |
|---|---|
| Revenue | SEK 630.39m |
| Cost of Revenue | SEK 421.23m |
| Gross Profit | SEK 209.16m |
| Other Expenses | SEK 198.27m |
| Earnings | SEK 10.88m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 33.18% |
| Net Profit Margin | 1.73% |
| Debt/Equity Ratio | 0% |
How did PROB perform over the long term?
See historical performance and comparison